Literature DB >> 24944468

Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.

Marco Scarpa1, Ignazio Castagliuolo1, Carlo Castoro1, Anna Pozza1, Melania Scarpa1, Andromachi Kotsafti1, Imerio Angriman1.   

Abstract

Ulcerative colitis (UC) is characterized by repeated flare-ups of inflammation that can lead to oncogenic insults to the colonic epithelial. UC-associated carcinogenesis presents a different sequence of tumorigenic events compared to those that contribute to the development of sporadic colorectal cancer. In fact, in UC, the early events are represented by oxidative DNA damage and DNA methylation that can produce an inhibition of oncosuppressor genes, mutation of p53, aneuploidy, and microsatellite instability. Hypermethylation of tumor suppressor and DNA mismatch repair gene promoter regions is an epigenetic mechanism of gene silencing that contribute to tumorigenesis and may represent the first step in inflammatory carcinogenesis. Moreover, p53 is frequently mutated in the early stages of UC-associated cancer. Aneuploidy is an independent risk factor for forthcoming carcinogenesis in UC. Epithelial cell-T-cell cross-talk mediated by CD80 is a key factor in controlling the progression from low to high grade dysplasia in UC-associated carcinogenesis.

Entities:  

Keywords:  Carcinogenesis; Colorectal cancer; Immune surveillance; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24944468      PMCID: PMC4051917          DOI: 10.3748/wjg.v20.i22.6774

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  127 in total

1.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: its regulation by interferon gamma and interleukin-10.

Authors:  J Li; Y Yang; H Inoue; M Mori; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1996-12       Impact factor: 6.968

4.  Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitis.

Authors:  Marco Scarpa; Marina Bortolami; Attilio Cecchetto; Diego Faggian; Andromachi Kotsafti; Cesare Ruffolo; Filippo Navaglia; Anna Pozza; Renata D'Incà; Mario Plebani; Giacomo C Sturniolo; Imerio Angriman
Journal:  Eur J Cancer       Date:  2010-11-08       Impact factor: 9.162

5.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

Review 6.  Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract.

Authors:  C J van der Woude; J H Kleibeuker; P L M Jansen; H Moshage
Journal:  Apoptosis       Date:  2004-03       Impact factor: 4.677

Review 7.  Roles of COX-1 and COX-2 in gastrointestinal pathophysiology.

Authors:  C Sakamoto
Journal:  J Gastroenterol       Date:  1998-10       Impact factor: 7.527

8.  Loss of heterozygosity and microsatellite instability in non-neoplastic mucosa from patients with chronic ulcerative colitis.

Authors: 
Journal:  Int J Mol Med       Date:  1998-08       Impact factor: 4.101

9.  Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.

Authors:  B D Greenwald; N Harpaz; J Yin; Y Huang; Y Tong; V L Brown; T McDaniel; C Newkirk; J H Resau; S J Meltzer
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

10.  Unequivocal demonstration that malondialdehyde is a mutagen.

Authors:  A K Basu; L J Marnett
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

View more
  33 in total

Review 1.  Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer.

Authors:  Marie Muller; Franck Hansmannel; Djesia Arnone; Myriam Choukour; Ndeye Coumba Ndiaye; Tunay Kokten; Rémi Houlgatte; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-04-08       Impact factor: 4.623

2.  Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23/IL-17 axis.

Authors:  Qin Zhu; Peifen Zheng; Xinyu Chen; Feng Zhou; Qiaona He; Yuefeng Yang
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

3.  Post-colonoscopy colorectal cancer rates in the Swedish IBD and non-IBD population: Something missed or something faster?

Authors:  Yonca Yılmaz Ürün; Yücel Üstündağ
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

4.  Development and endoscopic appearance of colorectal tumors are characterized by the expression profiles of miRNAs.

Authors:  Yoshihito Nakagawa; Yukihiro Akao; Tomomitsu Tahara; Hiromi Yamashita; Mitsuo Nagasaka; Tomoyuki Shibata; Naoki Ohmiya
Journal:  Med Mol Morphol       Date:  2018-03-21       Impact factor: 2.309

Review 5.  New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.

Authors:  Honor J Hugo; C Saunders; R G Ramsay; E W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-21       Impact factor: 2.673

6.  How does inflammation drive mutagenesis in colorectal cancer?

Authors:  Chia Wei Hsu; Mark L Sowers; Willie Hsu; Eduardo Eyzaguirre; Suimin Qiu; Celia Chao; Charles P Mouton; Yuri Fofanov; Pomila Singh; Lawrence C Sowers
Journal:  Trends Cancer Res       Date:  2017

7.  Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β.

Authors:  Shakir M Saud; Weidong Li; Zane Gray; Matthias S Matter; Nancy H Colburn; Matthew R Young; Young S Kim
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-02

Review 8.  Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.

Authors:  Håvard E Danielsen; Manohar Pradhan; Marco Novelli
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

9.  Overexpression of MTH1 and OGG1 proteins in ulcerative colitis-associated carcinogenesis.

Authors:  Yoshiteru Kumagae; Minako Hirahashi; Katsumi Takizawa; Hidetaka Yamamoto; Masaki Gushima; Motohiro Esaki; Takayuki Matsumoto; Masafumi Nakamura; Takanari Kitazono; Yoshinao Oda
Journal:  Oncol Lett       Date:  2018-05-25       Impact factor: 2.967

10.  Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis.

Authors:  Giulia Santi; Pierre Michetti; Florian Froehlich; Jean-Benoît Rossel; Valérie Pittet; Michel H Maillard
Journal:  Inflamm Intest Dis       Date:  2020-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.